| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Head Of R&D | Chief Medical Officer
3 companies
Dupont Jakob is an EVP, Head Of R&D at Atara Biotherapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sell | 2,152 | $12.53 | $26,968.86 | -2.3% | +34.5% | -62.8% | |
| May 18, 2021 | ATRA Atara Biotherapeutics, Inc. | EVP, Head Of R&D | Sell | 5,184 | $14.55 | $75,427.20 | -5.2% | -14.6% | -64.7% | |
| Dec 30, 2019 | GOSS Gossamer Bio, Inc. | Chief Medical Officer | Sale+OE | 41,994 | $15.04 | $631,538.11 | -100% | - | - |